ACE and type 1 diabetes mellitus: In order to control vascular microangiopathy in patients affected by IDDM with proteinuria and hypertension, we added aminaphtone to standard therapy for IDDM (insulin) and hypertension (angiotensin-converting enzyme inhibitors).